[1]
R. Diaz Beveridge, “Management of Advanced Pancreatic Cancer with Gemcitabine Plus Erlotinib: Efficacy and Safety Results in Clinical Practice”, JOP. J Pancreas (Online), vol. 15, no. 1, pp. 19–24, Jan. 2014.